Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Gemtesa is the brand name for vibegron, a prescription medicine for overactive bladder in adults. It can reduce urinary urgency, frequent urination, and leakage associated with a sudden urge to urinate. It belongs to a class of medicines called beta-3 adrenergic agonists.
read more about gemtesa ...Gemtesa treats symptoms of overactive bladder in adults. It is also approved for adult men with overactive bladder who are taking medicine for benign prostatic hyperplasia. A clinician can assess whether another condition is contributing to urinary symptoms.
Gemtesa activates beta-3 receptors in the bladder. This relaxes the bladder muscle while it fills with urine. The bladder can then hold more urine, which can reduce urgency and trips to the bathroom.
The recommended dose is one 75 mg tablet by mouth once daily, with or without food. The tablet can be swallowed whole with water. Adults who cannot swallow it whole can crush it, mix it with a tablespoon of applesauce, and take it immediately with water.
Reported side effects include headache, nausea, diarrhea, and urinary tract infection. Gemtesa can cause difficulty emptying the bladder, particularly in people with bladder outlet obstruction or those taking certain other overactive bladder medicines. Swelling of the face, tongue, or throat requires urgent medical care.
Yes. Gemtesa can be taken with or without food.
Yes. Adults can mix a crushed tablet with a tablespoon of applesauce and take it immediately with water.
It can treat overactive bladder symptoms in adult men who are taking medicine for benign prostatic hyperplasia. It does not replace their prostate medicine.
Contact the prescriber promptly. Urinary retention is a recognized risk that needs medical assessment.
GEMTESA- vibegron tablet, film coated. DailyMed (National Library of Medicine). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25f21d25-14f8-4fda-91f6-7aa8b68aa1c8. Date Accessed October 6, 2026.
Overactive bladder - Diagnosis and treatment. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/overactive-bladder/diagnosis-treatment/drc-20355721. Date Accessed October 6, 2026.
Vibegron. MedlinePlus. https://medlineplus.gov/druginfo/meds/a621015.html. Date Accessed October 6, 2026.
Vibegron (Gemtesa): Uses & Side Effects. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/23856-vibegron-oral-tablets. Date Accessed October 6, 2026.
Vibegron (oral route) - Side effects & dosage. Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/vibegron-oral-route/description/drg-20507673. Date Accessed October 6, 2026.